Menu
Back to Journals » Patient Preference and Adherence » Volume 17
Original Research
Real-World Comparison of First-Line Treatment Adherence Between Single-Agent Ibrutinib and Acalabrutinib in Patients with Chronic Lymphocytic Leukemia
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 6,740 | Dovepress* | 6,108+ | 83 | 6,191 | |
| PubMed Central* | 632 | 220 | 852 | ||
| Totals | 6,740 | 303 | 7,043 | ||
| *Since 23 August 2023 | |||||
View citations on PubMed Central and Google Scholar